Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+54.3%
5Y CAGR+71.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+54.3%/yr
Annual compound
5Y CAGR
+71.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
14.9x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $118.93M | +26.8% |
| 2024 | $93.80M | +121.7% |
| 2023 | $42.32M | +30.8% |
| 2022 | $32.36M | +163.0% |
| 2021 | $12.30M | +53.9% |
| 2020 | $8.00M | -6.8% |
| 2019 | $8.58M | - |